natgillin/translations-raw huggingface dataset:
Physicians should ensure that appropriate dose adjustment of maraviroc is made when maraviroc is co- administered with CYP3A4 inhibitors and/or inducers since maraviroc concentrations and its therapeutic effects may be affected (see sections 4.2 and 4.5).
Zdravnik mora poskrbeti za ustrezno prilagoditev odmerka maraviroka, kadar je le-ta uporabljen sočasno z zaviralci in/ali induktorji CYP3A4; takšna sočasna uporaba namreč lahko vpliva na koncentracijo maraviroka in njegove terapevtske učinke (glejte poglavji 4.2 in 4.5).
Physicians should ensure that women and men taking mycophenolate understand the risk of harm to the baby, the need for effective contraception, and the need to immediately consult their physician if there is a possibility of pregnancy.
Zdravniki morajo zagotoviti, da bolnice in bolniki, ki jemljejo mikofenolat razumejo tveganje za škodo otroku, nujnost uporabe učinkovite kontracepcije in nujnost, da se nemudoma posvetujejo s svojim zdravnikom, če obstaja možnost, da je prišlo do zanositve.
Physicians should ensure that women and men taking mycophenolate understand the risk of harm to the baby, the need for effective contraception, and the need to immediately consult their physician if there is a possibility of pregnancy.
Zdravniki morajo zagotoviti, da bolnice in bolniki, ki jemljejo mikofenolat, razumejo tveganje za škodo otroku, nujnost uporabe učinkovite kontracepcije in nujnost, da se nemudoma posvetujejo s svojim zdravnikom, če obstaja možnost, da je prišlo do zanositve.
Physicians should exercise caution when administering Ilaris to patients with infections, a history of recurring infections, or underlying conditions which may predispose them to infections.
Zdravniki morajo biti previdni, kadar dajejo zdravilo Ilaris bolnikom z okužbo, z anamnezo ponavljajočih se okužb ali z boleznijo, zaradi katere so bolniki nagnjeni k okužbam.
Physicians should exercise caution when considering the use of Benepali in patients with a history of recurring or chronic infections or with underlying conditions that may predispose patients to infections, such as advanced or poorly controlled diabetes.
Zdravniki morajo biti zelo previdni, kadar se odločajo za zdravljenje z zdravilom Benepali pri bolnikih s ponavljajočimi se ali kroničnimi okužbami v anamnezi ali z drugimi osnovnimi stanji (kot je na primer napredovala ali neurejena sladkorna bolezen), ki bi lahko povečala dovzetnost bolnika za okužbe.
Physicians should exercise caution when considering the use of Enbrel in patients with a history of recurring or chronic infections or with underlying conditions that may predispose patients to infections such as advanced or poorly controlled diabetes.
Zdravniki morajo biti zelo previdni, kadar se odločajo za zdravljenje s tem zdravilom pri bolnikih s ponavljajočimi se ali kroničnimi okužbami v anamnezi ali z drugimi osnovnimi stanji (kot je na primer napredovala ali neurejena sladkorna bolezen), ki bi lahko povečala dovzetnost bolnika za okužbe.
Physicians should exercise caution when considering the use of Enbrel in patients with a history of recurring or chronic infections or with underlying conditions that may predispose patients to infections, such as advanced or poorly controlled diabetes.
Zdravniki morajo biti zelo previdni, kadar se odločajo za zdravljenje s tem zdravilom pri bolnikih s ponavljajočimi se ali kroničnimi okužbami v anamnezi ali z drugimi osnovnimi stanji (kot je na primer napredovala ali neurejena sladkorna bolezen), ki bi lahko povečala dovzetnost bolnika za okužbe.
Physicians should exercise caution when considering the use of filgrastim in patients with sickle cell disease and only after careful evaluation of the potential risks and benefits.
Pri odločitvi za uporabo filgrastima pri bolnikih s srpastocelično anemijo morajo biti zdravniki previdni; za takšno zdravljenje naj se odločijo le po skrbni presoji možnih tveganj in koristi.
Physicians should exercise caution when considering the use of MabThera in patients with a history of recurring or chronic infections or with underlying conditions which may further predispose patients to serious infection (see section 4.8).
Pri odločanju za uporabo zdravila MabThera morajo biti zdravniki previdni pri bolnikih z anamnezo ponavljajočih se ali kroničnih okužb ali s sočasnimi boleznimi, zaradi katerih so lahko dodatno nagnjeni k resnim okužbam (glejte poglavje 4.8).
Physicians should monitor patients’ weight, and when appropriate encourage increased caloric intake if weight loss is considered to be of clinical significance.
Zdravniki naj spremljajo telesno maso bolnikov in jih po potrebi vzpodbujajo k povečanju vnosa kalorij, kadar je izguba telesne mase klinično pomembna.
Physicians should provide clear instructions for self-injection.
V tem primeru mora zdravnik dati natančna navodila za samoinjiciranje.
Physicians should refer to current HIV treatment guidelines for the management of HIV infection in patients co-infected with hepatitis B virus (HBV) or hepatitis C virus (HCV)
Za zdravljenje okužbe z virusom HIV pri bolnikih, ki so hkrati okuženi z virusom hepatitisa B (HBV) ali virusom hepatitisa C (HCV), naj zdravniki upoštevajo trenutno veljavne smernice za zdravljenje HIV.
Physicians should refer to current HIV treatment guidelines for the optimal management of HIV infection in patients co-infected with hepatitis B virus (HBV).
Zdravnik mora upoštevati trenutne smernice za zdravljenje okužbe s HIV za optimalno obravnavo okužbe s HIV pri bolnikih, ki so sočasno okuženi z virusom hepatitisa B (HBV).
Physicians should review the patient’s vaccination status and follow current immunisation guidelines prior to MabThera therapy.
Zdravniki morajo pred zdravljenjem z zdravilom MabThera pregledati status cepljenja bolnikov in upoštevati veljavne smernice za cepljenje.
Physicians should therefore remain continuously informed by responsible representatives for their local laboratory on the performance of the locally used method for concentration determination of sirolimus.
Zato morajo zastopniki, odgovorni za njihov lokalni laboratorij, stalno informirati zdravnike o izvajanju metode za določanje koncentracije sirolimusa, ki se uporablja lokalno.
Physicians should therefore weigh the risks versus the benefits when prescribing Latuda to patients with Parkinson’s disease.
Pri predpisovanju zdravila Latuda bolnikom s Parkinsonovo boleznijo mora zdravnik presoditi o tveganjih v primerjavi s koristmi.
Physicians should try to ensure that appropriate contraception is used, and should use clinical judgement when assessing whether oral contraceptives, or the doses of the oral contraceptive components, are adequate based on the individual patients clinical situation (see section 4.5).
Zdravniki morajo poskusiti zagotoviti, da bolnice uporabljajo ustrezno kontracepcijo, in naj pri ocenjevanju, ali zadostujejo peroralni kontraceptivi oziroma odmerki posameznih sestavin v peroralnih kontraceptivih, uporabljajo klinično presojo na podlagi kliničnega položaja posameznih bolnic (glejte poglavje 4.5).
Physicians should try to ensure that appropriate contraception is used, and should use clinical judgement when assessing whether oral contraceptives, or the doses of the oral contraceptive components, are adequate, based on the individual patients clinical situation (see section 4.5).
Zdravniki morajo poskusiti zagotoviti, da bolnice uporabljajo ustrezno kontracepcijo, in naj pri ocenjevanju, ali zadostujejo peroralni kontraceptivi oziroma odmerki posameznih sestavin v peroralnih kontraceptivih, uporabljajo klinično presojo na podlagi kliničnega položaja posameznih bolnic (glejte poglavje 4.5).
Physicians should use caution when prescribing filgrastim in patients with sickle cell trait or sickle cell disease.
Zdravniki morajo biti previdni pri predpisovanju filgrastima pri bolnikih s srpastocelično zasnovo ali srpastocelično anemijo.
Physicians should use caution when using Benepali in patients who have congestive heart failure (CHF).
Zdravniki morajo biti previdni, kadar predpišejo zdravilo Benepali bolnikom s kongestivnim srčnim popuščanjem (KSP).
Physicians should use caution when using Enbrel in patients who have congestive heart failure (CHF).
Zdravniki morajo biti previdni, kadar predpišejo zdravilo Enbrel bolnikom s kongestivnim srčnim popuščanjem (KSP).
Physicians should weigh the risks versus the benefits when prescribing INVEGA to patients with Parkinson’s Disease or Dementia with Lewy Bodies (DLB) since both groups may be at increased risk of Neuroleptic Malignant Syndrome as well as having an increased sensitivity to antipsychotics.
Zdravnik mora pretehtati tveganja in koristi predpisovanja zdravila INVEGA bolnikom s Parkinsonovo boleznijo ali demenco z Lewyevimi telesci (DLB), ker imata obe skupini lahko povečano tveganje za pojav nevroleptičnega malignega sindroma in tudi povečano občutljivost na antipsihotike.
Physicians should weigh the risks versus the benefits when prescribing Sycrest to patients with Parkinson’s disease or dementia with Lewy Bodies (DLB) since both groups may be at increased risk of neuroleptic malignant syndrome as well as having an increased sensitivity to antipsychotics.
Zdravnik mora pri predpisovanju zdravila Sycrest bolnikom s Parkinsonovo boleznijo ali bolnikom, ki imajo demenco z Lewyevimi telesci (DLB), pretehtati tveganja in koristi uporabe antipsihotikov, ker imata lahko obe omenjeni skupini bolnikov večje tveganje za nastanek nevroleptičnega malignega sindroma, lahko pa sta tudi bolj občutljivi za antipsihotike.
Physicians should weigh the risks versus the benefits when prescribing TREVICTA to patients with Parkinson’s disease or Dementia with Lewy Bodies (DLB) since both groups may be at increased risk of Neuroleptic Malignant Syndrome as well as having an increased sensitivity to antipsychotics.
Zdravnik mora pretehtati tveganja in koristi predpisovanja zdravila TREVICTA bolnikom s Parkinsonovo boleznijo ali z demenco z Lewyjevimi telesci, ker imata obe skupini lahko povečano tveganje za pojav nevroleptičnega malignega sindroma in tudi povečano občutljivost na antipsihotike.
Physicians should weigh the risks versus the benefits when prescribing Xeplion to patients with Parkinson’s Disease or Dementia with Lewy Bodies (DLB) since both groups may be at increased risk of Neuroleptic Malignant Syndrome as well as having an increased sensitivity to antipsychotics.
Zdravnik mora pretehtati tveganja in koristi predpisovanja antipsihotikov, vključno z zdravilom Xeplion bolnikom s Parkinsonovo boleznijo ali demenco z Lewyevimi telesci (DLB), ker imata obe skupini lahko povečano tveganje za pojav nevroleptičnega malignega sindroma in tudi povečano občutljivost na antipsihotike.
Physicians treating patients with Zonegran should try to ensure that appropriate contraception is used, and should use clinical judgement when assessing whether oral contraceptives (OCs), or the doses of the OC components, are adequate based on the individual patient’s clinical situation.
Zdravniki, ki zdravijo bolnice z zdravilom Zonegran, bi morali poskrbeti, da te med zdravljenjem uporabljajo ustrezno kontracepcijo in bi morali uporabiti klinično presojo pri oceni, ali so peroralni kontraceptivi (OC – “oral contraceptive”) ali odmerki komponent OC ustrezni glede na bolničino klinično situacijo.
Physicians treating patients with zonisamide should try to ensure that appropriate contraception is used, and should use clinical judgement when assessing whether oral contraceptives (OCs), or the doses of the OC components, are adequate based on the individual patient’s clinical situation.
Zdravniki, ki zdravijo bolnike z zonisamidom, bi morali poskrbeti, da ti med zdravljenjem uporabljajo ustrezno kontracepcijo in bi morali uporabiti klinično presojo pri oceni ali so peroralni kontraceptivi (OC – “oral contraceptive”) ali odmerki komponent OC ustrezni glede na bolnikovo klinično situacijo.
Physicians were allowed to change their patient’s NRTI regimen upon entry into the study.
Zdravniki so ob vključitvi bolnika v študijo smeli zamenjati NRTI-režim.
Physicians who express an interest in initiating self-administration for specific patients are provided with a HAT pack for those patients.
Zdravnikom, ki imajo interes, da bi pri določenih bolnikih uvedli samoinjiciranje zdravila, je za takšne bolnike na voljo paket za usposabljanje za samoinjiciranje doma.
Physician’s guides to prescribing
mernice za predpisovanje za zdravnike,
Physician’s overall assessment
Zdravnikova celotna ocena
Physician’s overall assessment of treatment effectiveness:
Zdravnikova celotna ocena učinkovitosti zdravljenja:
Physician’s overall assessment was performed in five of the above studies as a broad measure of asthma control performed by the treating physician.
Zdravnikovo celotno oceno so uporabili v petih od zgoraj omenjenih študij kot široko merilo obvladovanja astme, opravil pa jo je lečeči zdravnik.
Physico-chemical data suggest excretion of colistimethate sodium in human milk.
Na podlagi fizikalno-kemijskih podatkov se predvideva izločanje natrijevega kolistimetata v materino mleko.
Physico-chemical stability of the reconstituted product has been shown for 24 hours at 2°C to 8°C.
Potrjena fizikalno- kemijska stabilnost rekonstituiranega zdravila je 24 ur pri temperaturi med 2°C in 8°C.
Physiologically-based pharmacokinetic modelling has shown that after four weeks treatment with temsirolimus, the AUC of midazolam can be increased 3-to-4 fold and Cmax around 1.5-fold when midazolam is taken within a few hours after the start of the temsirolimus infusion.
Farmakokinetično modeliranje na osnovi fizioloških lastnosti je pokazalo, da se lahko po 4-tedenskem zdravljenju s temsirolimusom, AUC midaziolama poveča od 3- do 4-krat, Cmax pa 1,5-krat v primeru aplikacije midazolama v roku nekaj ur po začetku infuzije temsirolimusa.
Physiotherapy/exercise
fizioterapija/telesna vadba;
Ph–positive CML is a cancer of the blood which makes the body produce too many of a specific type of white blood cell called granulocytes.
Ph-pozitivna kronična mieloična levkemija je krvni rak, zaradi katerega telo izdeluje preveliko količino določenih belih krvnih celic, imenovanih granulociti.
PI
Rasa
PI 83 %
312 (284, 339)
PI = protease inhibitor
PI = zaviralec proteaze
PI and rifabutin should be
PI in rifabutinom je potrebna
PI-experienced
Že zdravljeni z zaviralci proteaz
PI-experienced patients Amprenavir
Bolniki, ki so se predhodno že zdravili z zaviralci proteaz Amprenavir
PI-experienced patients Amprenavir
Bolniki, ki so se že zdravili z zaviralci proteaz Amprenavir
PI; except in combination with
Zaviralci HIV proteaz (PI)
PIANO is a single-arm, Phase II trial evaluating the pharmacokinetics, safety, tolerability, and efficacy of INTELENCE in 101 antiretroviral treatment-experienced HIV-1 infected paediatric patients 6 years to less than 18 years of age and weighing at least 16 kg.
PIANO je preskušanje II. faze z eno skupino bolnikov v katerem so ocenjevali farmakokinetiko, varnost, prenosljivost in učinkovitost zdravila INTELENCE pri 101 s HIV-1 okuženem pediatričnem bolniku, ki se je že zdravil s protiretrovirusnimi zdravili, starem 6 let do manj kot 18 let in s telesno maso najmanj 16 kg.
Picato 150 mcg/g (n=277)
Zdravilo Picato 150 µg/g (n = 277)
Picato 150 mcg/g gel ingenol mebutate Cutaneous use
Picato 150 µg/g gel ingenoli mebutas dermalna uporaba
Picato 150 micrograms/gram gel ingenol mebutate
Picato 150 mikrogramov/gram gel ingenol mebutat (ingenoli mebutas)
Picato 500 mcg/g (n=226)
Zdravilo Picato 500 µg/g (n = 226)
Picato 500 mcg/g gel ingenol mebutate Cutaneous use
Picato 500 µg/g gel ingenoli mebutas dermalna uporaba
Picato 500 micrograms/gram gel ingenol mebutate
Picato 500 mikrogramov/gram gel ingenol mebutat (ingenoli mebutas)
Picato contains the active substance ingenol mebutate.
Zdravilo Picato vsebuje zdravilno učinkovino ingenol mebutat.
Picato has no or negligible influence on the ability to drive and use machines.
Zdravilo Picato nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
Picato ingenol mebutate
Picato ingenol mebutat
Pick up the box
Primite škatlo.
Pick up the pre-filled syringe from the flat work surface.
Napolnjeno injekcijsko brizgo vzemite v roke.
Pick up the pre-filled syringe, hold the body of the syringe with one hand
Telo brizge držite z eno roko.
Pick up the syringe and remove the needle cover
Vzemite brizgo in snemite pokrovček z igle.
Pick up the syringe from your work surface.
Vzemite v roko brizgo.
Pick up the syringe with the needle pointing up.
Primite brizgo tako, da je igla obrnjena navzgor.
Pick up the vial and the syringe, keeping them attached and straight.
Dvignite vialo in injekcijsko brizgo tako, da se držita in sta ravni.
Pick up your syringe and slowly inject the contents of the syringe into the vial of powder.
Primite brizgo in počasi injicirajte vsebino brizge v vialo s praškom.
Pictures of rash according to different grades
slike izpuščajev različnih stopenj
Pierce the capsule by firmly pressing together both side buttons at the same time.
Kapsulo predrete tako, da oba stranska gumba istočasno močno stisnete skupaj.
Pierce the capsule by pressing firmly the blue button with your thumb as far as it will go, then release the button.
Kapsulo predrete tako, da s palcem močno pritisnete na moder gumb kolikor gre in nato gumb spustite.
Pierce the capsule:
Predrite kapsulo:
Pig
Prašič
Pig Type
Kategorija prašiča
Piglet, 3-4 weeks
Pujski, stari 3-4 tedne
Piglet, newborn
Pujski, novorojeni
Piglets from 3 weeks of age: Administer one 0.5 ml dose by intramuscular injection.
Pujski od tretjega tedna starosti: odmerek po 0.5 ml intramuskularno.
Piglets:
Pujski:
Piglets: Active immunisation of piglets to reduce faecal excretion of PCV2 and virus load in blood, and as an aid to reduce PCV2 linked clinical signs, including wasting, weight loss and mortality as well as to reduce virus load and lesions in lymphoid tissues associated with PCV2 infection.
Pujski: Aktivna imunizacija pujskov za zmanjšanje izločanja PCV2 s fecesom in količine virusa v krvi in kot pomoč pri zmanjšanju kliničnih znakov, povezanih s PCV2, vključno s hiranjem, izgubo telesne teže in smrtnosti ter tudi zmanjšanje prisotnosti virusa in poškodb na limfoidnem tkivu, povezanih z okužbo s PCV2.
Piglets: The efficacy of the vaccine in the face of intermediate to high levels of maternally derived antibodies has been demonstrated.
Pujski: Dokazana je bila učinkovitost cepiva pri pujskih s srednjimi do visokimi vrednostmi maternalnih protiteles.
Pigment changes (discolouration) of ocular tissues, including the retina have been reported in long- term clinical studies with retigabine, sometimes but not always in conjunction with pigment changes of the skin, lips or nails (see below paragraph and section 4.8).
V dolgotrajnih kliničnih študijah retigabina so bile opisane pigmentne spremembe (spremembe barve) očesnih tkiv, vključno z mrežnico, včasih - a ne vedno - skupaj s pigmentnimi spremembami na koži, ustnicah ali nohtih (glejte spodnji odstavek in poglavje 4.8).
Pigment changes (discolouration) of ocular tissues, including the retina have been reported in long- term clinical studies withretigabine, sometimes but not always in conjunction with pigment changes of the skin, lips or nails (see below paragraph and section 4.8).
V dolgotrajnih kliničnih študijah retigabina so bile opisane pigmentne spremembe (spremembe barve) očesnih tkiv, vključno z mrežnico, včasih - a ne vedno - skupaj s pigmentnimi spremembami na koži, ustnicah ali nohtih (glejte spodnji odstavek in poglavje 4.8).
Pigment changes (discolouration) of ocular tissues, including the retina, have been observed after several years of treatment.
Po več letih zdravljenja so opažali pigmentne spremembe (spremembe barve) očesnih tkiv, vključno z mrežnico.
Pigment changes (discolouration) of the skin, lips or nails have been reported in long-term clinical studies with retigabine, sometimes but not always in conjunction with pigment changes of ocular tissues (see above paragraph and section 4.8).
V dolgotrajnih kliničnih študijah retigabina so bile opisane pigmentne spremembe (spremembe barve) kože, ustnic in nohtov, včasih - a ne vedno - skupaj s pigmentnimi spremembami očesnih tkiv (glejte zgornji odstavek in poglavje 4.8).
Pigmentation
pigmentacije,
Pigmentation abnormal, erythema
nenormalna pigmentacija kože, eritem
Pigmentation disorder
motnje pigmentacije
Pigmentation disorder Erythrodermic psoriasis
motnja pigmentacije eritrodermična psoriaza
Pigmentation disorder Skin hyperpigmentation
motnja pigmentacije hiperpigmentacija kože
Pigmentation lip Post inflammatory pigmentation change Seborrhoea
pigmentacija ustnic, povnetna pigmentacijska sprememba,
pigmentation of periocular skin
pigmentacija periokularne kože
Pigs
Prašiči:
Pigs (for fattening)
Prašiči (za pitance).
Pigs (for fattening).
Prašiči (za pitance).
Pigs (for fattening).
Prašiči (za pitanje)
Pigs (gilts and sows), from six months of age onwards.
Svinje in mladice.
Pigs (gilts, sows and piglets from 3 weeks of age).
Prašiči (mladice, svinje in pujski od 3 tednov starosti).
Pigs (gilts, sows and piglets from 3 weeks of age).
Prašiči (mladice, svinje in pujski, starejši od 3 tednov).
Pigs (gilts, sows and piglets)
Prašiči (mladice, svinje in pujski)
Pigs (piglets)
Prašiči (pujski).
Pigs (sows, gilts)
Prašiči (svinje in mladice)
Pigs (sows/gilts)
prašiči (svinje in mladice)
Pigs and chickens
Prašiči in piščanci
Pigs and rabbits should not receive products containing monensin, salinomycin or narasin, during or at least 5 days before or after treatment with valnemulin.
Med zdravljenjem ali vsaj 5 dni pred in 5 dni po končanem zdravljenju z valnemulinom prašiči in kunci ne smejo dobiti zdravil, ki vsebujejo monenzin, salinomicin ali narazin.
Pigs and sheep: IM.
Prašiči in ovce: i.m.
Pigs and sheep: IM.
Prašiči: i.m.
Pigs Carton Box
Prašiči Kartonska škatla
Pigs either received Metacam or a placebo injection.
Prašiči so prejeli bodisi injekcijo zdravila Metacam ali placebo.
Pigs for fattening.
Prašiči pitanci
Pigs from 6 months of age which have not been previously vaccinated with the product should be given two injections with an interval of 3–4 weeks.
Pri prašičih, starih 6 mesecev ali več, ki še niso bili cepljeni s tem zdravilom, je treba dati dve injekciji z razmikom 3–4 tednov.
Pigs from 6 months of age which have not been previously vaccinated with the product should be given two injections with an interval of 3–4 weeks.
Pri prašičih, starih 6 mesecev ali več, ki še niso bili cepljeni s temcepivom, je treba dati dve injekciji z razmikom 3–4 tednov.
Pigs, horses: meat and offal: 5 days
Prašiči, konji: meso in organi: 5 dni
Pigs.
Prašiči
pigs: 13 days; sheep: 16 days
Prašiči:13 dni Ovce: 16 dni
Pigs: 16 days
Prašiči: 16 dni.
Pigs: Can be used during pregnancy and lactation.
Prašiči: Zdravilo lahko uporabljate med brejostjo in laktacijo.
Pigs: Can be used during pregnancy and lactation.
Prašiči: Zdravilo se lahko uporablja med brejostjo in laktacijo.
Pigs: for intramuscular use.
Prašiči: –intramuskularno.
Pigs: I.M.
Prašiči: i.m.
Pigs: IM injection.
Prašiči i.m. injekcija
Pigs: IM injection.
Prašiči: i.m. injekcija
Pigs: IM injection.
Prašiči: i.m. injekcija.
Pigs: IM.
Prašiči: i.m.
Pigs: meat and offal: 5 days
Prašiči: meso in organi: 5 dni
Pigs: meat and offal: 5 days
Prašiči: meso in organi: 5 dni.
Pigs: meat and offal: 5 days.
Prašiči: meso in organi: 5 dni
Pigs: Meat and offal: 5 days.
Prašiči: meso in organi: 5 dni.
Pigs: Single I.M. injection.
Prašiči: Enkratna i.m. injekcija.
Pigs: Single IM injection.
Prašiči: Enkratna i.m. injekcija.
Pike estimate of the treatment hazard ratio, <1 indicates a lower risk for Tyverb plus capecitabine compared with Trastuzumab plus capecitabine.
Pikova ocena razmerja ogroženosti terapije < 1 kaže manjše tveganje s kombinacijo Tyverba in kapecitabina kot s kombinacijo trastuzumaba in kapecitabina.
Piles(haemorrhoids)
hemoroidi,
Pilocarpine, used to treat glaucoma (a severe eye disease).
pilokarpin, ki se uporablja za zdravljenje glavkoma (huda bolezen oči),